Danske Bank A/S Alkermes Plc. Transaction History

Danske Bank A/S

  • $1.95 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025
BUY
$26.13 - $30.46 $874,597 - $1.02 Million
33,471 New
33,471 $1 Million
Q2 2025

Dec 18, 2025
SELL
$26.59 - $32.65 $253,322 - $311,056
-9,527 Reduced 17.06%
46,321 $1.33 Million
Q1 2025

Dec 18, 2025
BUY
$28.08 - $36.0 $628,346 - $805,572
22,377 Added 66.85%
55,848 $1.84 Million

Others Institutions Holding ALKS

# of Institutions
401
Shares Held
176M
Call Options Held
901K
Put Options Held
400K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email